BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Introducing Powerdot, Paving The Way in Smart Muscle Stimulation

  Also known as EMS or e-stim, electrical muscle stimulation is an effective performance and recovery method that uses electrical impulses to cause a contraction in targeted muscles.

  November 7, 2017

   · 

  3 min read
• Policy

  Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks

  In its consideration of GHR tests, the FDA seeks to strike a balance that provides for an efficient pathway to bring these tests to consumers, without sacrificing the assurances offered by FDA oversight.

  November 7, 2017

   · 

  5 min read
• BioMidwest

  IQMS Presentation at MD&M Minneapolis Will Examine the Top Factors That Drive Medical Device Manufacturers’ Growth

  The event runs November 8-9, 2017 at the Minneapolis Convention Center in Minneapolis, MN.

  November 7, 2017

   · 

  2 min read
• Business

  DJO Global Announces Date for Release of Third Quarter 2017 Results

  DJO Global, Inc., a leading global provider of medical technologies designed to get and keep people moving, today announced the following information for the release of its third quarter 2017 financial results and a conference call to discuss those results.

  November 7, 2017

   · 

  2 min read
• TherapeuticsMD Announces Third Quarter 2017 Financial Results

  Net revenue from the company’s prescription prenatal vitamin business was approximately $4.4 million for the third quarter of 2017 compared with net revenue of approximately $5.5 million for the prior year’s quarter.

  November 7, 2017

   · 

  10 min read
• Business

  Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017

  At 4:30 p.m. Eastern Time Aurinia’s management will host a conference call to discuss the company’s financial results for the third quarter 2017 and provide a general business update.

  November 7, 2017

   · 

  1 min read
• Business

  Mallinckrodt plc Reports Earnings Results for Third Quarter of Fiscal 2017

  Net sales were $793.9M in the third quarter, down 10.5%, or 10.6% on a constant-currency basis.

  November 7, 2017

   · 

  51 min read
• Business

  Ardelyx Reports Third Quarter 2017 Operating Results and Clinical Progress

  Ardelyx, today provided an update on its clinical programs and reported financial results for the third quarter ended September 30, 2017.

  November 7, 2017

   · 

  11 min read
• Business

  Ionis Pharma Reports Financial Results and Highlights for Third Quarter 2017

  The Company ended the third quarter with over $1B in cash.

  November 7, 2017

   · 

  38 min read
• Business

  Compugen Reports Third Quarter 2017 Results

  R&D expenses for the third quarter of 2017 and nine months ended September 30, 2017 were $7.6M and $21.4M, respectively, compared with $6.0M and $18.2M in the comparable periods in 2016.

  November 7, 2017

   · 

  14 min read